Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (131)
Rein Therapeutics, Inc. (RNTX)
WINDSOR JAMES BRIAN — Director
Shares
25,000
Price
$1.00
Total Value
$25.00K
Shares Held After
27,046
% of Holdings
92.4%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,511
Price
$2.69
Total Value
$4.06K
Shares Held After
6,236
% of Holdings
24.2%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,034
Price
$2.69
Total Value
$5.47K
Shares Held After
6,013
% of Holdings
33.8%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,190
Price
$2.69
Total Value
$5.89K
Shares Held After
6,498
% of Holdings
33.7%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,748
Price
$2.69
Total Value
$4.70K
Shares Held After
6,441
% of Holdings
27.1%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,706
Price
$2.69
Total Value
$4.59K
Shares Held After
13,813
% of Holdings
12.4%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
200
Price
$1.68
Total Value
$336.00
Shares Held After
700
% of Holdings
28.6%
Processa Pharmaceuticals, Inc. (PCSA)
Bigora Sian — Chief Development Officer
Shares
1,986
Price
$2.69
Total Value
$5.34K
Shares Held After
7,496
% of Holdings
26.5%
Anika Therapeutics, Inc. (ANIK)
Griffin Stephen D. — Director
Shares
12,200
Price
$12.29
Total Value
$149.88K
Shares Held After
36,163
% of Holdings
33.7%
GE HealthCare Technologies Inc. (GEHC)
Jimenez Frank R — GC & Corporate Secretary
Shares
1,750
Price
$60.45
Total Value
$105.79K
Shares Held After
93,932
% of Holdings
1.9%
GE HealthCare Technologies Inc. (GEHC)
Arduini Peter J — Director
Shares
4,169
Price
$59.92
Total Value
$249.83K
Shares Held After
259,424
% of Holdings
1.6%
Elite Health Systems Inc. (EHSI)
jeereddi Prasad Anjaneya — Director
Shares
1,707
Price
$1.08
Total Value
$1.84K
Shares Held After
227,423
% of Holdings
0.8%
Telix Pharmaceuticals Ltd (TLX)
Behrenbruch Christian — Director
Shares
33,435
Price
$14.87
Total Value
$497.18K
Shares Held After
20,742,935
% of Holdings
0.2%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
100
Price
$1.75
Total Value
$175.00
Shares Held After
500
% of Holdings
20.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,000
Price
$1.11
Total Value
$5.55K
Shares Held After
280,766
% of Holdings
1.8%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
35,000
Price
$17.62
Total Value
$616.70K
Shares Held After
1,786,039
% of Holdings
2.0%
Telix Pharmaceuticals Ltd (TLX)
Behrenbruch Christian — Director
Shares
34,500
Price
$14.48
Total Value
$499.56K
Shares Held After
20,709,500
% of Holdings
0.2%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
25,000
Price
$18.02
Total Value
$450.50K
Shares Held After
1,751,039
% of Holdings
1.4%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.52
Total Value
$45.18K
Shares Held After
3,062,000
% of Holdings
0.3%
NewcelX Ltd. (NCEL)
Samuel Olivier — Director
Shares
81,818
Price
$2.75
Total Value
$225.00K
Shares Held After
81,818
% of Holdings
100.0%
NewcelX Ltd. (NCEL)
Revel Michel — Director
Shares
54,545
Price
$2.75
Total Value
$150.00K
Shares Held After
957,530
% of Holdings
5.7%
ABBOTT LABORATORIES (ABT)
STARKS DANIEL J — Director
Shares
10,000
Price
$92.65
Total Value
$926.54K
Shares Held After
6,751,103
% of Holdings
0.1%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
250,923
Price
$3.64
Total Value
$913.13K
Shares Held After
12,684,884
% of Holdings
2.0%
NovaBridge Biosciences (NBP)
Hagler Mark Arnold — President and Chief Commercial Officer
Shares
230,000
Price
$2.51
Total Value
$577.30K
Shares Held After
230,000
% of Holdings
100.0%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
38,880
Price
$3.53
Total Value
$137.08K
Shares Held After
12,433,961
% of Holdings
0.3%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
280,381
Price
$3.50
Total Value
$982.03K
Shares Held After
12,395,081
% of Holdings
2.3%
ABBOTT LABORATORIES (ABT)
Boudreau Philip P — EVP AND CFO
Shares
2,200
Price
$91.50
Total Value
$201.30K
Shares Held After
2,200
% of Holdings
100.0%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Neman-Ebrahim Yousha — Chief Clinical Officer
Shares
500
Price
$4.88
Total Value
$2.44K
Shares Held After
134,760
% of Holdings
0.4%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.90
Total Value
$49.00K
Shares Held After
3,052,000
% of Holdings
0.3%
ProMIS Neurosciences Inc. (PMN)
Kirwin Patrick D. — Director
Shares
4,000
Price
$11.33
Total Value
$45.32K
Shares Held After
4,653
% of Holdings
86.0%
Nasus Pharma Ltd (NSRX)
Teleman Dan Benjamin — Director
Shares
2,900
Price
$3.76
Total Value
$10.90K
Shares Held After
156,991
% of Holdings
1.8%
Hepion Pharmaceuticals, Inc. (HEPA)
Purcell Michael J. — Director
Shares
1,250,000
Price
$0.04
Total Value
$50.00K
Shares Held After
1,250,000
% of Holdings
100.0%
Hepion Pharmaceuticals, Inc. (HEPA)
Appajosyula Sireesh — Director
Shares
1,250,000
Price
$0.04
Total Value
$50.00K
Shares Held After
1,250,000
% of Holdings
100.0%
Hepion Pharmaceuticals, Inc. (HEPA)
LoPriore Vincent S — Director
Shares
1,250,000
Price
$0.04
Total Value
$50.00K
Shares Held After
6,250,000
% of Holdings
20.0%
Hepion Pharmaceuticals, Inc. (HEPA)
Stetz Gary S. — Director
Shares
1,250,000
Price
$0.04
Total Value
$50.00K
Shares Held After
1,250,000
% of Holdings
100.0%
Hepion Pharmaceuticals, Inc. (HEPA)
LoPriore Vincent S — Director
Shares
5,000,000
Price
$0.04
Total Value
$200.00K
Shares Held After
5,000,000
% of Holdings
100.0%
Prelude Therapeutics Inc (PRLD)
Bonita David P — Director
Shares
1,126,126
Price
$4.44
Total Value
$5.00M
Shares Held After
1,126,126
% of Holdings
100.0%
Prelude Therapeutics Inc (PRLD)
Bonita David P — Director
Shares
1,689,189
Price
$4.44
Total Value
$7.50M
Shares Held After
11,808,945
% of Holdings
14.3%
Prelude Therapeutics Inc (PRLD)
ORBIMED ADVISORS LLC — Director
Shares
1,126,126
Price
$4.44
Total Value
$5.00M
Shares Held After
1,126,126
% of Holdings
100.0%
Prelude Therapeutics Inc (PRLD)
ORBIMED ADVISORS LLC — Director
Shares
1,689,189
Price
$4.44
Total Value
$7.50M
Shares Held After
11,808,945
% of Holdings
14.3%
JOINT Corp (JYNT)
JOBSON CHARLES E — 10% Owner
Shares
509
Price
$8.58
Total Value
$4.37K
Shares Held After
1,645,803
% of Holdings
0.0%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
72,912
Price
$0.33
Total Value
$24.06K
Shares Held After
133,574
% of Holdings
54.6%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
400
Price
$1.23
Total Value
$492.00
Shares Held After
275,766
% of Holdings
0.1%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
100,000
Price
$1.51
Total Value
$151.00K
Shares Held After
9,978,988
% of Holdings
1.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
600
Price
$1.23
Total Value
$738.00
Shares Held After
275,366
% of Holdings
0.2%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
100,000
Price
$1.58
Total Value
$158.00K
Shares Held After
9,878,988
% of Holdings
1.0%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
40,690
Price
$3.88
Total Value
$157.97K
Shares Held After
12,114,700
% of Holdings
0.3%
Zivo Bioscience, Inc. (ZIVO)
STROME MARK E — 10% Owner
Shares
100,000
Price
$2.00
Total Value
$200.00K
Shares Held After
572,942
% of Holdings
17.5%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
34,636
Price
$0.73
Total Value
$25.28K
Shares Held After
177,821
% of Holdings
19.5%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
40,114
Price
$3.57
Total Value
$143.25K
Shares Held After
12,074,010
% of Holdings
0.3%
Showing 1–50 of 131 transactions (page 1 of 3)